Department of Rehabilitation and Human Performance, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
J Neurotrauma. 2021 Dec;38(23):3186-3194. doi: 10.1089/neu.2021.0216.
Traumatic brain injury (TBI) is a risk factor for later-life dementia. Clinical and pre-clinical studies have elucidated multiple mechanisms through which TBI may influence or exacerbate multiple pathological processes underlying Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The National Institutes of Health hosts triennial ADRD Summits to inform a national research agenda, and the 2019 ADRD Summit was the first to highlight "TBI and AD/ADRD Risk" as an emerging topic in the field. A multidisciplinary committee of TBI researchers with relevant expertise reviewed extant literature, identified research gaps and opportunities, and proposed draft research recommendations at the 2019 ADRD Summit. These research recommendations, further refined after broad stakeholder input at the Summit, cover four overall areas: 1) Encourage crosstalk and interdisciplinary collaboration between TBI and dementia researchers; 2) Establish infrastructure to study TBI as a risk factor for AD/ADRD; 3) Promote basic and clinical research examining the development and progression of TBI AD/ADRD neuropathologies and associated clinical symptoms; and 4) Characterize the clinical phenotype of progressive dementia associated with TBI and develop non-invasive diagnostic approaches. These recommendations recognize a need to strengthen communication and build frameworks to connect the complexity of TBI with rapidly evolving AD/ADRD research. Recommendations acknowledge TBI as a clinically and pathologically heterogeneous disease whose associations with AD/ADRDs remain incompletely understood. The recommendations highlight the scientific advantage of investigating AD/ADRD in the context of a known TBI exposure, the study of which can directly inform on disease mechanisms and treatment targets for AD/ADRDs with shared common pathways.
创伤性脑损伤 (TBI) 是晚年痴呆的一个风险因素。临床和临床前研究已经阐明了多种机制,通过这些机制,TBI 可能会影响或加剧阿尔茨海默病和阿尔茨海默病相关痴呆症 (AD/ADRD) 的多种病理过程。美国国立卫生研究院每三年举办一次 AD 峰会,为国家研究议程提供信息,2019 年的 AD 峰会首次将“TBI 和 AD/ADRD 风险”作为该领域的一个新出现的主题。一个由具有相关专业知识的 TBI 研究人员组成的多学科委员会审查了现有文献,确定了研究差距和机会,并在 2019 年 AD 峰会上提出了研究建议草案。这些研究建议在峰会期间广泛征求利益相关者的意见后进一步细化,涵盖四个总体领域:1)鼓励 TBI 和痴呆症研究人员之间的交流和跨学科合作;2)建立研究 TBI 作为 AD/ADRD 风险因素的基础设施;3)促进研究 TBI AD/ADRD 神经病理学和相关临床症状发展和进展的基础和临床研究;4)描述与 TBI 相关的进行性痴呆的临床表型并开发非侵入性诊断方法。这些建议认识到需要加强沟通并建立框架,将 TBI 的复杂性与快速发展的 AD/ADRD 研究联系起来。建议承认 TBI 是一种临床和病理异质性疾病,其与 AD/ADRD 的关联仍不完全清楚。这些建议强调了在已知 TBI 暴露背景下研究 AD/ADRD 的科学优势,这可以直接为 AD/ADRD 的疾病机制和治疗靶点提供信息,这些疾病具有共同的途径。